Translating heterologous proteins places significant burden on host cells, consuming expression resources leading to slower cell growth and productivity. Yet predicting the cost of protein production for any gene is a major challenge, as multiple processes and factors determine translation efficiency.
Introduction
To be able to build systems with increasingly more genes, not only is precise gene expression desirable, but it is also essential to have an understanding of the burden these will place on the host cell so that designs can be optimised to ensure robust growth and to prevent the deleterious mutations that arise in high-burden systems 1, 2, 3 . For any given gene, its burden is in the first instance the resource cost of maintaining and expressing the gene as needed 4, 5, 6, 7 . If the gene encodes a function, for example an enzyme, the impact of this can further cause a more specific role-based metabolic burden that adds to the expression burden, e.g. by consuming host cell metabolites and co-factors 8,9 . Research primarily in the model bacteria E. coli, has demonstrated that a lack of understanding of the burden of expressing additional genes affects our ability to predictively engineer cells 10, 11, 12, 13 .
To predict the burden of expressing a new gene from a synthetic construct, we first need to understand how much it is expressed and how this affects the cell's capacity for its own gene expression by consuming its resources. With synthetic biology tools and software it is now possible to define at the DNA sequence level both the amount of transcription (via the promoter) and the rate of translation initiation (via the RBS sequence) 14, 15 . Yet, the efficiency of translation is also known to be dependent on nucleotide composition 16 , secondary structure of the mRNA 17 , translational pausing 18 , the presence of rare codons or the use of rare amino acids 19, 20 , or in most cases combinations of all of the above and more. Given this complexity it is not surprising that it is currently impossible to look at a given gene DNA sequence or protein amino acid sequence and predict what impact its expression will have on the host cell.
In vivo measurements are therefore still essential for predicting the cost of protein expression. The relative costs of translation of proteins can be inferred from the in vivo outcomes of competition for resources, either simply by measuring changes in growth rate measurements 21 or by quantifying decreased production rate of a "capacity monitor" gene; a constitutively expressed and chromosomally-integrated reporter that acts as a proxy of available expression resources in the cell 4 .
However, in vivo measurements are a low-throughput process requiring time-consuming cloning and growth experiments 22, 23 . They often generate hard-to-deconvolute results because burden slows growth and potentially triggers secondary changes in global gene expression behaviour.
Cell-free lysates are a new emerging tool in synthetic biology that represents a promising approach for quantifying burden as they constitute simpler, non-growing genetic expression systems akin to cells, that effectively capture a snapshot of the same gene expression machinery. Indeed, the expression of protein-encoding constructs using E. coli cell lysates has been shown to match in vivo performance in many cases 24, 25, 26 . It also allows users to rapidly characterize a large number of synthetic constructs in parallel 27 , and batches of cell lysates can be prepared and stored frozen, purchased from companies or can be customised in terms of their make-up 28 .
Here, we combined cell lysate experiments, in vivo measurements in corresponding E. coli cells and mathematical modelling to demonstrate prediction of the impact of different genes and multigene systems on growing E. coli cells. We measured the resource consumption of a variety of protein coding sequences in both cell lysates and in vivo. Through this, we show that the competition for resources between a capacity monitor construct and the different protein coding sequences showed a correlation between cell lysate and in vivo data. Using a ribosome flow model, we extend predictions of burden in cells to systems expressing multiple genes of interest with different translation efficiencies, and in different growth conditions. By combining these efforts, we provide a novel method for rapid in vitro screening of synthetic parts designed to enable the prediction of the behaviour and expression efficiency of synthetic constructs and the impact they have on their host cell.
Results
Cell-free protein synthesis using E. coli lysates provides a rapid platform to quantify resource competition. Current methods to quantify burden all rely on in vivo measurement of cell performance and growth when hosting and expressing synthetic constructs 4, 29, 30 . As such, it typically requires several days of cloning, verification and assaying to obtain data that can be used to determine a gene's burden. However, groups using 'cell-free' protein synthesis systems have recently shown that the design-build-test cycle used in synthetic biology can be accelerated by characterising expression from DNA directly added to E. coli lysates 24, 25, 26, 27 .
In vivo, the burden of expression of synthetic constructs is caused by competition between the added genes and native genes for the resources needed for gene expression. Previously, we have shown that this can be measured by a decrease in the capacity of a cell to express a standard measurable gene chromosomally-integrated into E. coli that acts as a "capacity monitor" 4 ( Figure 1A) . Similarly, in cell-free experiments it has also been possible to observe competition for gene expression resources when using two different plasmids within the same cell lysate mix 31 . Therefore, as a proxy to measure resource competition in cell lysate, we constructed and tested a low-copy plasmid-based version of our previous capacity monitor ( Figure 1B) where superfolder gfp is expressed constitutively from a synthetic promoter with a strong RBS. Using the maximum GFP production rate (max dGFP/dt, see Supplementary Figure 1A ) measured during characterisation with this plasmid in cell lysates, we sought to measure available expression capacity and identify resource competition. To do this we first simply measured the max GFP production rate in 10 µl of cell lysate mix, with no competing plasmid, instead using increasing concentrations of the capacity monitor plasmid itself (Supplementary Figure 1B) . This revealed that the max GFP production rate reaches a plateau at 50 nM of plasmid DNA (Supplementary Figure 1B) . In addition, the max GFP production rate per DNA ( Figure 1C) can be used to observe the competition for resources; a decrease in max GFP production per DNA is measured when DNA concentration is higher than 30 nM ( Figure 1C) . This decrease highlights that the amount of resources is limited for the expression of GFP from a plasmid due to competition with the pool of other copies of this plasmid.
In vivo in E. coli the main cost of gene expression is attributed to translation 6, 29, 30, 32, 33 . However, in cell lysates, while NTPs and amino acids are added in excess, polymerases, ribosomes and their associated machinery (sigma factor, tRNAs, chaperones, initiation and release factors) are added at an unknown amount and thus, the cost of transcription or translation is unknown. In order to determine the relative contributions of transcription and translation to resource competition in cell lysates, we next introduced two different plasmids to each compete with the capacity monitor plasmid. The first plasmid contains the mkate gene, paired with a constitutive promoter (J23106) and a strong RBS, and was used to measure the cost of both transcription and translation. The second plasmid is the same but has a very weak RBS that produces no measurable mKate protein, and so imparts a transcriptional cost and a negligible translational cost. We added different concentrations of each plasmid to the cell lysate mix along with 30 nM of the capacity monitor plasmid and measured the corresponding max GFP production rates. These values were then normalised to the max GFP production rate when the capacity monitor plasmid alone was present (i.e. normalised max GFP production rate = 1.0 in a cell lysate mix containing only the capacity monitor plasmid).
No decrease in max GFP production rate was observed with addition of up to 20 nM of weak RBS plasmid, implying no competition for transcriptional resources at these concentrations ( Figure 1D) . In contrast, addition of the strong RBS plasmid at these concentrations gives a significant decrease in normalised max GFP production rate (Figure 1D) , indicating competition for translational resources in the cell lysate mix. Indeed, when 20 nM of a "competitor" plasmid is assayed with 30 nM of capacity monitor plasmid in cell lysate, translation is clearly the major cost. These conditions therefore offer a similar regime to those seen in vivo with E. coli where translation is the major cost of gene expression.
The cost of protein production in cell lysate assays correlates with costs observed in vivo. We next measured the burden of a collection of plasmids expressing mKate at different levels in the cell lysate in the conditions determined above and compared these to in vivo measurements. We constructed a library of plasmids with mkate under control of the same promoter (J23106) but different RBS sequences ( Supplementary Table 1 ) in order to affect burden only by altering translation initiation efficiency. These plasmids lead to a limited but measurable burden simply from overexpression of the mKate fluorescent protein and were assessed both by our previous in vivo capacity monitor approach (GFP production rate per cell) and by the cell lysate method (normalised max GFP production rate). Direct comparison between cell lysate and in vivo results yielded a linear relationship with good correlation (R 2 = 0.74, Figure 1E ). As the GFP production rate is a proxy of resource competition in both cell lysates and in E. coli, we can conclude that the competition for translational resources in the cell lysate matches those seen in in vivo.
Having demonstrated that cell lysate is predictive of in vivo burden when translation initiation rate is altered, we next looked to see if it can predict the burden of producing different proteins. First, we constructed a standard entry vector to enable the protein coding sequence of a Gene of Interest (GoI, Supplementary Table 2 ) to be rapidly cloned by Golden Gate DNA assembly into a standard format for our cell lysate assay (Supplementary Figure 1C) . This design leads to the GoI protein coding sequence being placed under constitutive expression (J23106) and fused downstream to mKate in order to allow expression to be verified. We constructed 3 different entry vectors, each with different RBS sequences in order to give a choice of expression levels. We selected the well-characterised B0034 RBS along with 2 Bicistronic Design (BCD2 and BCD21) sequences that ensure context-free, defined levels of translation initiation 34 .
The protein coding sequences of 7 genes with different lengths, functions and amino acid composition and 3 truncated versions of viob of different lengths ( Supplementary Table 2 ) were all cloned into the same entry vector with the BCD2. When assayed both in cell lysate and then in vivo in E. coli a wide range of burden was observed for this collection. The capacity monitor measurements from both cell lysate and in vivo experiments once again showed a good linear fit, with a R 2 = 0.76 ( Figure 1F) , demonstrating that the resource use in cell lysates of translating different proteins (and transcribing their different mRNAs) matches the resource use in E. coli. Similar results (linear fits) are obtained using the same measurements in cell lysate but with different growth media for the capacity characterisation in vivo ( Supplementary Figure 2A & B) . However, experiments done in M9 + Figure 2B) . This can be explained by the growth-rate dependent composition of E. coli 35 
Glucose lead to a different linear relationship between cell lysate and in vivo measurements (Supplementary

(see Supplementary Note 1, Supplementary Figure 2C & 2D).
A mathematical model to predict the in vivo burden of protein expression from cell lysate measurements. Synthetic constructs typically involve multiple heterologous proteins expressed at different rates. To predict the burden imposed by expressing genes at different rates we can use the competitive model of translation developed by Algar et al., previously used alongside our capacity monitor assay 4, 36 (Figure 2A) . This model describes the three steps of production of proteins: initial binding of ribosomes, translation elongation and ribosome release. The total number of ribosomesthe resource being competed foris fixed in this model and is also expected to be fixed in cell lysate experiments. The binding (a 1 ), unbinding (a -1 ) and initiation elongation (b 0 ) rates of ribosomes on an mRNA depend on the RBS strength (See Model simulations in Methods). The time needed by a ribosome bound to an mRNA to fully-translate a working protein is captured by a lumped parameter γ, which represents the elongation rate. This value will vary for each GoI depending on the protein being made and how efficiently it is translated. The parameters for the capacity monitor construct in the model are the same in all our simulations (i.e. the ribosome binding rate, a 1M = 0.0001 rib -1 RBS -1 s -1 ; the ribosome unbinding rate, a -1M = 200 rib-RBS -1 s -1 ; the translation initiation rate, b 0M = 1 s -1 ;
mRNA amount, size M ; and the elongation rate, γ M = 1 s -1 see Model simulations in Methods, 36 ). Overview of a mathematical model of competitive translation with a finite ribosome pool. The model represents the competition for ribosomes between the capacity monitor construct and a construct expressing a GoI. Free ribosomes bind to an unoccupied RBS at a rate a 1 (a 1 =a 1M *RBS strength) and either unbinds and returns to the free ribosome pool at a rate a −1 (a −1 =a −1M /RBS strength), or initiates translation at a rate b 0 (b 0 =b 0M *RBS strength). Once elongation has initiated, the ribosome moves along the transcript at a rate γ. The number of elongation steps depends on "size" (mRNA size / 30 bp as it is the footprint of each ribosome on an mRNA and better represents how many can be queued on a transcript). Each elongation step is considered to proceed at the same rate γ. Once the ribosome reaches the final position on the mRNA it returns to the free ribosome pool. (B) Heat maps of simulated capacity monitor (monitor output) when mRNA size and the γ value of a synthetic construct are varied while RBS strength is fixed. The first heat map is used to determine the γ value of each construct used in Figure 1F . The second heat map is used to deduce the monitor output using these calculated γ values. As the prediction is done for cell lysate, the in vivo predictions are deduced from the correlation between cell lysate and in vivo measurements as per Figure 1F Given that it is currently impossible to determine the rate γ for a gene based on its DNA or amino acid sequence, experimental characterisation is still required to determine the burden a GoI will impart when expressed in a cell. However, our cell lysate capacity measurements now offer a rapid and standardised method to quantify this parameter without the need for cloning. To demonstrate how these data can be used to predict the burden of genes in vivo, we first took measurements from Figure   1F (expression of GoI-mKate with BCD2) and simulated them with this model. RBS strength was set to a value of 2.6 using measurements of a plasmid expressing mKate alone with BCD2 (strong translation initiation rate calculated in Supplementary Figure 3) . Parameters in the model were set (as described in Methods, model simulations) in order to simulate the monitor output (equivalent of the normalised max GFP production rates in cell lysate) as a function of the mRNA size and γ value.
The measured capacities and known mRNA sizes were then used to determine the γ value for each of the considered genes (Figure 2B) . We then used this model-inferred γ value for each of these genes in an equivalent simulation but with a weaker RBS, specifically the BCD21, which we experimentally measured to correspond to RBS strength=2.1 (weaker translation initiation rate calculated in Supplementary Figure 3 ). Using this simulation, we first predicted the cell lysate normalised max GFP production rate for these new constructs, and then using the known linear relationship between lysate and in vivo measurements (Figure 1F , y = 0.7x + 0.19, with y = Normalised max GFP production and x = Normalised Capacity), we extended this to predict in vivo performance ( Figure   2B ). After then building and measuring the burden of this library of BCD21 constructs in E. coli we were able to determine that our model-based predictions of burden matched in vivo data with good correlation (R 2 =0.74, Figure 2B ). Thus, with only the cell lysate data and knowledge of the mRNA length and RBS strength, we are able to predict the burden of different genes of interest expressed at different levels in E. coli.
Further investigation of our model shows that increasing the cost of GoI production by increasing RBS strength (a higher RBS strength implies a higher translation initiation rate and, therefore, a larger amount of ribosome binding to an mRNA) or/and decreasing γ values (a low γ value corresponds a slower global elongation rate, which leads to ribosomes staying longer on an mRNA) leads to different monitor outputs profiles as mRNA amounts are varied (Figure 2C ). An increase of mRNA amount can be achieved through an increase of promoter strength, plasmid or gene copy number. In Figure 2C , the mRNA amount is used to simulate the impact of an increase of the copy number of a gene on the monitor output. At low RBS strength (e.g. 0.5), the mRNA amount and monitor output (GFP production rate) exhibit an almost linear relationship when the γ value is higher than 0.02 s -1 (note that the γ value for the monitor (gfp gene) is 1 s -1 ). In this context, the impact of the translation of several genes should be easily deduced as the burden is additive (i.e. the decrease in monitor output is the sum of the decreases in monitor output values for each gene measured individually). Even with a strong RBS (i.e. high RBS strength), a linear or close-to-linear relationship between the mRNA amount and monitor output is observed if the γ value is higher than 1 s -1 . However, at high RBS strengths, a decrease of the γ value leads to a faster-than-linear decrease in the monitor output as mRNA amount increases (e.g. RBS strength=2 in Figure 2C) . This means that genes that have a high cost of translation (low γ values) expressed from strong RBS sequences do not simply have additive burden, but instead will yield a nonlinear decrease in monitor output as mRNA numbers increase.
Using cell lysate measurements, we experimentally demonstrated this effect by comparing the normalised max GFP production rate from the monitor construct when it competes against expression of a gene with a high γ value (mkate, γ = 1.4 s -1 ) and with a strong RBS (RBS strength=2.6) versus competing against expression of a gene with a low γ value (viob-mkate, γ = 0.6 s -1 ) and a strong RBS (RBS strength =2.4). To mimic increased mRNA levels, we simply added more DNA for these two plasmid constructs. As predicted by our model we saw a linear relationship for the high γ GoI (Figure   2D , upper graph), and a nonlinear relationship for the low γ GoI (Figure 2D, lower graph) .
Predicting the burden of in vivo expression of a pathway operon.
As an exemplar case to predict in vivo burden of multiple genes, we used the four gene pathway for the biosynthesis of beta-carotene, a metabolite of interest for synthetic biology that is used industrially in nutritional supplements, cosmetics and animal feed 37 , and offers applications in medicine too 38 . We took the genes from Erwinia uredovora 39, 40 , codon-optimised these for E. coli and characterised the individual burden of each gene's expression in our standard cell lysate assay using our vector with BCD2. This gave us the γ value of each enzyme (Figure 3A, Supplementary Figure 4 and Supplementary Note 2). We then used MoClo Golden Gate DNA assembly 41 to construct a collection of 17 operons expressing all four enzymes at a variety of levels. To ensure diversity in both transcription and translation of the genes, the operons were constructed with one of three different constitutive promoters and with partiallyrandomised RBS sequences for each enzyme (Figure 4A, Supplementary Figure 5A) .
The model relies on 4 parameters to make predictions of the burden caused by the production of an operon: mRNA size, γ value, RBS strength and mRNA amount. The mRNA size of each enzyme is known and the γ values are determined from the cell lysate capacity assay. However, the mRNA amount and the RBS strengths are estimated using values from previous work (see Methods, model simulations) and using the RBS Calculator 14 (see Supplementary Figure 5 , Supplementary Note 3). As the four genes in the operon exhibited a γ value higher than 1 s -1 (as may be expected for codon optimised genes), we assumed burden of expression would be additive and used the model to predict resource consumption for the 17 different operon versions. For the first round of predictions we made the initial assumption that the total burden of the operon in vivo would entirely be due to the cost of expressing the genes and that there would be no burden caused by the specific role of the genes, i.e.
we assumed no significant burden on metabolism through conversion host metabolites into betacarotene. However, when we compared the predicted effect on capacity from our model with subsequent measurements taken in E. coli (Figure 3B) we only saw a weak correlation (R 2 =0.44).
Upon quantifying the colour of the different E. coli we observed a wide diversity in beta-carotene production from the different designs (Supplementary Figure 6) , and thus it became evident that the in vivo burden of each operon must also relate to the metabolic cost of running the pathway in the host cell, not just the cost of expression of the enzymes. Expression of the enzymes depletes the cell of key metabolites, such as pathway precursors farnesyl pyrophosphate (FPP) and isopentenyl pyrophosphate (IPP) involved in the terpenoid backbone synthesis 42 , and this presumably affects cell growth.
Figure 3: Predicting the burden of operon designs for the beta-carotene biosynthesis pathway. (A)
Diagram of the beta-carotene pathway and the γ values for the four enzyme-encoding sequences as measured by the cell lysate capacity assay (Supplementary Figure 3) . The operon is designed with partially-randomised RBS sequences and one of three different promoters: J23113 (weak), J23106 (medium) or J23100 (strong). (B) Model-predicted burden of each operon design compared to the measured capacity of E. coli expressing the operons with or without an inactivating mutation in the crtE gene. The orange intensity in each circle represents the beta-carotene production as level measured for each strain (see in Supplementary Figure 5 ). Error bars show standard error of three independent repeats (C) Model-predicted burden of each operon design compared to the measured capacity of E. coli expressing the working pathway operons (same data as panel B). The diagonal dot line represents equality between the predicted and measured normalised capacity. Grey bars indicate the difference between the predicted and measured normalised capacity of the 17 operons. The righthand plot compares the relative differences between the predicted and measured normalised capacity for the 17 operons and the strain-only control.
To verify this, we targeted a mutation to the active site of the first enzyme of the pathway, CrtE, in order to inactivate it and effectively cease metabolic conversion for the whole pathway (see Methods, construction of the beta-carotene operon). The mutation was designed to have no effect on the expression of the enzymes and so gene expression burden was still seen when the 17 operons, each with this mutation, were re-characterised in vivo for their effect on E. coli capacity. With no betacarotene production, our predictions for the burden of each design now showed a much closer match to in vivo data (R 2 =0.78, Figure 3B ). Our cell lysate-assay-based model is, thus, able to predict the impact on the host of expressing multiple genes and as expected gives the most accurate predictions when the burden is the result only of competition for gene expression resources. Interestingly, this means that our platform offers potential further use for separating "expression burden" from "metabolic burden" by simply subtracting the predicted capacity from the cell lysate data from the subsequent capacity of cells running the pathways as measured in vivo. The resulting difference calculated from this gives a value of burden that is not predicted to be from gene expression ( Figure   3C, Supplementary Figure 6 ). How this value relates to the burden of pathway productivity, metabolite consumption and intermediate accumulation is discussed in Supplementary Note 4.
Discussion
This work demonstrates that a standard cell lysate-based assay can be used to quantify the burden of expressing a protein coding sequence and provides an otherwise missing parameter for predicting the burden synthetic gene expression places on E. coli. Using a collection of plasmids with a range of RBS sequences and different protein coding sequences we demonstrated here that competition for translational resources in cell lysates serves as a good predictor for in vivo behaviour in E. coli.
Furthermore, we provide a standard entry vector to enable quick, standardised characterisation of a GoI with cell lysates and we accompany this with a mathematical model that enables prediction of the in vivo performance from cell lysate measurement data. The cell lysate assay effectively quantifies a global parameter, we here term γ, which is the combination of all sequence-dependent parameters (nucleotide composition, secondary structure of the mRNA, translational pausing, presence of rare codons or use of rare amino acids) involved in the resource costs for translating a protein coding sequence. Quantifying this is necessary for accurate approximation of the burden of protein expression as there is currently no in silico tool to predict the cost, time or efficiency of translation for a given RNA or amino acid sequence. When combined with estimates of RBS strength from the RBS Calculator 14 , these cell lysate measurements enable predictions both for single genes when there are changes in the translation efficiency, and for multigene systems such as the operon example here.
Another exciting finding from this work is the possibility that our platform can separate "expression burden" from "metabolic burden", something that cannot easily be done in vivo due to the combined effects that all types of burden have on host cell growth rate. Our characterisation of beta-carotene pathway operons demonstrates that these two types of burden are jointly-responsible for decreased growth rates of hosts expressing heterologous genes to produce metabolites. Most methods for metabolic pathway optimisation seek to produce the most product whilst doing so with the minimal cost of expression of the enzymes 43, 44, 45 . Quantifying the individual contributions to burden of both gene expression and pathway productivity offers a new tool for designing the most productive pathways and investigating the mechanistic causes of burden in more depth.
To further deconstruct the mechanisms of expression burden and quantify resource use at a molecular level, future iterations of our cell lysate approach could make use of defined in vitro expression systems such as PURE Express (NEB), which contains known quantities of purified components such as polymerases and ribosomes 46 . Full control of the make-up of cell lysates would provide a route towards determining the main components that are required for efficient gene expression and could be used to investigate which factors are limiting for different genes. For example, charged tRNAs may be limiting for genes with rare codons, while chaperones may be limiting for genes requiring complex folding. Such an approach would likely reveal hidden mechanisms and constraints in gene expression, highlighting basic components to increase in cells when needing to efficiently overexpress certain genes, while also providing a more complete list of the components needed for the construction of minimal cells.
Further exploration with cell lysates and/or the PURE system will likely reveal the key molecular interactions involved in the translation elongation and release processes, and ideally enable the development of a biophysical model suitable for predicting the protein cost based only on the input of a DNA sequence. Such a predictor will complete the set of tools (with transcription [21] and translation initiation [22] predictors) necessary to design and develop reliable circuits in silico and accelerate the construction of large and more complex systems and pathways using synthetic biology.
Methods
Strains and Growth media
Plasmids were transformed using standard procedures 47 
Construction of the GoI-mkate library
The high-copy plasmid pSB1C3 (BioBricks Foundation, Supplementary Data), chloramphenicolselectable, was used as a backbone to construct the standard entry vector for GoI insertion (Supplementary Figure 1C) . To construct the platform: we first PCR amplified pSB1C3 (forward primer: taagccagccccgacacccg / reverse primer: tgaaccacagagtgattaat) and lacZ under control of Plac promoter flanked by BsaI restriction sites (forward primer: gcagctggcacgacaggttt / reverse primer: ttatgcggcatcagagcaga). Second, the linkermkate sequence was codon optimised and ordered on GeneArt with the RBS sequences (BCD2 and B0034). The different parts were then assembled and cloned using the Gibson Assembly method 49 to obtain the standard entry vector described in Supplementary Figure 1C .
The GoI ( Supplementary Table 2 ) were all obtained using biobricks of the iGEM Parts Registry as template and PCR amplified to be flanked by the proper BsaI restriction sites (ggtctcannnn). Golden
Gate assemblies were set up by pipetting 40 fmol of backbone and insert, 0.5 µl of BsaI (NEB UK), 0.5 µl of T7 DNA ligase (NEB UK), 1 µl T4 buffer (NEB UK) and completed with water for final volume of 10 µl. Then the mix was put in a thermocycler for 30 following cycles: 42°C for 2 minutes / 6°C for 5 minutes / 55°C for 1 hour / 80°C for 10 minutes.
Construction of the beta-carotene operons
The beta-carotene operons were build using MoClo toolkit 41 . The Level 0 library is composed of constitutive promoters of the Anderson collection (J23114, J23113, J23100, J23106 and J23115), a random collection of RBSs, the 4 enzymes of the beta-carotene pathway and the terminator T1 41 . The level 1 was designed to put each enzyme under the control of a random RBS and to place the genes of the beta-carotene operons in the following order at the final level: crtE, crtB, crtI and crtY. The cloning was done using Golden Gate assembly as previously described, and then transformed in DH10B-GFP.
Two constructs (B3-1 str and B10-2 str, containing promoter J23100) were obtained by PCR amplification to introduce mutations in the "weak" promoter sequence J23113 (phosphorylated forward primer: tacggctagctcagtcctaggtatagtgctagcgcaagggcccaag reverse primer:
ttcacagagtggcctcgtga) of previously obtained constructs (B3-1 and B10-2). The resulting PCR fragments were ligated using T4 DNA ligase and transform in DH10B-GFP.
All the mutated crtE constructs were obtained by PCR amplification (forward primer:
gccgctatgccctgcatggacg, reverse primer: cgcggcttcgctgatcctt) and T4 ligation to introduce mutations in crtE leading to an inactivated CrtE enzyme. The mutation of crtE (from gacgat to gccgct) was chosen in order to modified the active site of crtE deduced by sequence homology of crtE sequences from Erwinia uredovora 50 , Erwinia herbicola 50 , Rhodobacter capsulatus 50 , Arabidopsis thaliana 5152 and Euglena gracilis 52 .
Cell lysate mix preparation and reactions
The cell lysate preparation is based on the protocol of Sun et al. 28 . The protocol was modified by using sonication 53 The remaining protocol follows the procedure described in 28 for Day 3, Step 37. mRNA and protein synthesis are performed by the molecular machineries present in the extract, with no addition of external enzymes. The Amino Acid Solution and Energy Solution described in 28 
Burden assay in vivo and data analysis
For burden measurements in DH10B-GFP, cells were grown at 37 °C overnight with aeration in a shaking incubator in 5 ml of defined supplemented fructose M9 media with chloramphenicol (35 μg/ml). In the morning, 20 μl of each sample was diluted into 1 ml of fresh medium and grown at 37°C with shaking for another hour. We then transferred 200 μL OD 600 into a 96-well plate (Costar), placed samples in a Synergy HT Microplate Reader (BioTek) and incubated them at 37°C with orbital shaking at medium setting, performing measurements of GFP (excitation (ex.), 485 nm; emission (em.), 528 nm), RFP (ex., 590 nm; em., 645 nm), OD (600 nm) and OD (700 nm) every 10 min.
Growth were calculated using OD 700 with:
growth rate at t2= [ln(OD(t3))ln(OD(t1))] / (t3 -t1), with t2 = time of the mid exponential phase, t3 = t2 + 0.5 hr and t1 = t2 -0.5 hr.
Protein production rates per hour were calculated with:
GFP production rate at t2 = [(total GFP(t3)total GFP(t1)) / (t3 -t1)] / OD(t2), and RFP production rate at t2 = [(total RFP(t3)total RFP(t1)) / (t3 -t1)] / OD(t2).
The normalised capacity stands for the GFP production rate measured in strains with the DH10B-GFP containing a plasmid divided by the GFP production rate measured in DH10B-GFP without any plasmid. Protein expression rates per hour were calculated with:
Resource competition assay in cell lysate and data analysis
GFP production rate at t2 = (total GFP(t3)total GFP(t1)) / (t3 -t1), and RFP production rate at t2 = (total RFP(t3)total RFP(t1)) / (t3 -t1).
The maximal expression rate value was selected as described in Figure 1C . The normalised max GFP production rate stands for the max GFP production rate measured in a cell lysate mix containing the capacity monitor plasmid and another plasmid divided by the max GFP production rate measured in a cell lysate mix with only the capacity monitor plasmid.
Beta-carotene measurements
E. coli were incubated with aeration in a shaking incubator in 5ml of Minimum media M9 supplemented with 0.5% fructose at 37°C during 24 hours. Cells were harvested using centrifugation at 4000 rpm for 10 minutes (Eppendorf, centrifuge 5810R). Pellet was re-suspended in 300 μL acetone, homogenised by vortexing and incubated at 55°C for 15 min. Supernatant was collected after 1 min centrifugation at 14000 rpm (Eppendorf, centrifuge 5424). 100 μL of water was added to 100 μL of samples and OD (450 nm) was measured in a Synergy HT Microplate Reader (BioTek).
Model simulations
We used the competitive model of translation developed by Algar et al. 36 . Simulations were done using the key parameters obtained from Bionumbers.org and calculated in 35 
